Back

ProCap Insights · April 22, 2026

Amazon's GLP-1 move just opened a compelling short on a telehealth leader

Amazon launched a full-stack GLP-1 weight loss program, bundling branded drugs from Novo Nordisk and Eli Lilly with same-day delivery and cheap insurance pricing. The market sold off HIMS, NVO, LLY, and AMGN indiscriminately, but the damage is not evenly distributed.

Subscribe to read the full report

Unlimited access to every research report we publish.

Already a member?